StockSelector.com
  Research, Select, & Monitor Monday, December 17, 2018 7:40:35 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Revance Therapeutics, Inc.$19.91($.79)(3.82%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Revance Therapeutics, Inc. has an overall rank of 6615 out of 7471 stocks based on 5 positive rankings and 11 negative rankings.

Positive Rankings
Debt-to-Equity
Revance Therapeutics rank is 184
Highest Cash Growth
Revance Therapeutics rank is 324
Low Put/Call
Revance Therapeutics has a low Put/Call ratio of 0.36 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Revance Therapeutics is ranked 992.
Oversold Stochastics
Revance Therapeutics rank is 1319
Up EPS Surprise
Revance Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Price-to-Sales
Revance Therapeutics rank is 56
Negative Net Margin
Revance Therapeutics rank is 86
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Negative Revenue Growth
Revance Therapeutics rank is 185
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Revance Therapeutics is ranked 457.
Negative ROA
Revance Therapeutics rank is 640
Negative ROE
Revance Therapeutics rank is 666
High vPut/Call
Revance Therapeutics has a high Put/Call ratio of 1.32 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Revance Therapeutics is ranked 1082.
90 Day Loss
Revance Therapeutics rank is 1349
Price-to-Book
Revance Therapeutics rank is 1671
10 Day Loss
Revance Therapeutics rank is 3638







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.